Company Financials

Hanmi Pharm. Co. Ltd Financials

South Korean won

business Hanmi Pharm. Co. Ltd Company Profile

Main Stock Listing

KRX: 128940

Market Capitalization ₩3.252 Trillion as of Jan. 1, 2025

Market Cap History

Valuations Metrics as of Jan. 25, 2025

Trailing PE 21.26
Forward PE 16.50
Price to Sales TTM ₩2.07
Price to Book MRQ
Enterprise to Revenue 2.52
Enterprise to EBITDA 10.87

Financial Reports as of Sep. 30, 2024

Financials

Fiscal Year Ends 2023-12-31
Most Recent Quarter 2024-09-30
Profit Margin 11.75%
Operating Margin 15.37%
Return on Assets TTM 8.67%
Return on Equity TTM 18.22%

Income Statement

Revenue TTM ₩1,568,781,107,200
Revenue per Share TTM ₩123662.79
Quarterly Revenue Growth 10.30%
Gross Profit TTM ₩829,249,343,220
EBITDA ₩492,725,174,940
Net Income to Common TTM ₩184,376,590,336
Diluted EPS TTM ₩11522.00
Quarterly Earnings Growth YoY 188.10%

Balance Sheet

Total Cash MRQ ₩246,889,496,576
Total Cash per Share MRQ ₩19470.45
Total Debt MRQ
Total Debt to Equity MRQ 42.55
Current Ratio MRQ 1.09
Book Value per Share MRQ

Cash Flow

Operating Cash Flow TTM ₩253,078,044,672
Levered Free Cash Flow TTM ₩158,889,754,624

128940 Stock Info as of Jan. 25, 2025

Stock Statistics

Shares Outstanding 12,680,200
Float Shares 6,202,146
Avg 10 Volume 53,300
Avg 30 Volume None
Shares Short None
Short Ratio
Short % of Shares %
% Held by Insiders 50.56%
% Held by Institutions 21.82%

Stock Price Summary

Beta 0.47
Fifty Two Week Low ₩243500.00
Fifty Two Week High ₩375000.00
Fifty Two Week Change -36.53%
Day 50 MA ₩310980.00
Day 200 MA ₩308610.00

Dividends and Splits

Forward Annual Dividend Rate ₩1000.00
Forward Annual Dividend Yield 0.41%
Trailing Annual Dividend Rate ₩250.00
Trailing Annual Dividend Yield 0.10%
Payout Ratio 5.84%
Dividend Date
Ex Dividend Date 2024-06-27
Last Split Factor
Last Split Date 2023-12-27